The event organizers selected Raleigh for their inaugural event given the Triangle region’s reputation for being an important ...

Bamboo Therapeutics, a next-generation gene therapy company based in Chapel Hill, has been acquired by the pharmaceutical giant Pfizer of New York. Pfizer, which had acquired a 22 percent stake in ...

The North Carolina Biotechnology Center awarded 14 grants and loans totaling $1,287,335 to bioscience companies, universities and non-profit organizations in the first quarter of its fiscal year. The ...

Arbiom, an agricultural biotechnology company based in Durham, says on its website, “We’re already using wood for our buildings, furniture, floors and more. Why not re-imagine wood as food?” The ...

North Carolina’s global leadership in biomanufacturing has drawn another spotlight with a White House announcement that President Donald Trump will be visiting the Triangle on Monday, July 27, to a ...

E. Norris Tolson, president and CEO of the North Carolina Biotechnology Center, will discuss the rewards and challenges confronting the state's wide-ranging biotechnology sector at a breakfast for ...

An exciting group of startups innovating in health care pitched as part of the April 27 event, “Aligning Health Care Innovation in North Carolina: Health Systems, Payers, Innovators, and the Quintuple ...

Durham-based Humacyte, founded by three female scientists in 2004, has received marketing approval from the U.S. Food and ...

Pancreatic cancer is an elusive and deadly disease. It often has no initial symptoms, and there are no reliable tests for early detection. The mortality rate is 75 percent within a year of diagnosis, ...

Pappas Capital, a Durham-based investor in early-stage life sciences companies, has appointed Karen LeVert as venture partner. She will help expand the firm’s Specialized Fund Management business – ...